First, Chen et al. (2018) observed the expression of METTL3 increased abnormally in liver cancer and increased cell proliferation in vitro, resulting in promoted tumorigenicity in vivo (Xu et al., 2017). This evidence concerns the gene METTL3 and liver cancer.